Jenny Inglefield is a VP, Hematology at CSL. She possess expertise in pharmaceutical industry, product launch, hospital sales, pharmaceutical sales, gastroenterology and 21 more skills. Colleagues describe her as "I am writing to express my strong recommendation for Jennifer Inglefield, whom I closely worked during her time as Global Product Strategy Lead for the rare genetic brands at Shire and Takeda. Jen is an exceptional leader who brings tremendous drive and energy to her work. She approaches her work with a strong focus on strategy, seeing it through to implementation. She also feels a deep commitment for the patients and families we are serving for in the pharmaceutical industry. During our time working together, I had the pleasure of seeing firsthand how she excelled in guiding the cross-functional teams and bringing people together to work towards a common goal. Some of the examples of her accomplishments in her role as a Global Product Strategy Lead were the development and roll out of an early diagnosis strategy and a focused life cycle strategy for two of our main products on the global level, or her fantastic management of supply challenges, just to name a few. Her strategic approach is highly focused, and she is skilled at developing and executing plans that deliver measurable results. One of the things I most admire about Jen is her dedication to her work which is contagious, and she inspires others to be their best selves. Overall, I would highly recommend Jen for any leadership or strategy position. She has exceptional drive, brings people together, and delivers results. It was a pleasure to work alongside her, and I know she will be an asset to any organization.", "Jenny was a highly effective and respected global access lead as part of our global product team. She built strong relationships with all the key countries and knew the intricacies of the various reimbursement models and how best to address each one in a rare disease setting with limited data. She combines a strong team spirit and drive to win with subject matter expert levels of knowledge about reimbursement and commercialization of rare diseases.", and "I worked with Jenny for approximately 12 months as an external vendor providing consultancy support across market access projects in the run up to product launch. Jenny understood the need for, and showed great skill in developing strong and highly productive collaborative relationships both with external vendors and internal colleagues. Jenny displays passion for her role and exhibits a breadth and depth of knowledge, combined with mental agility and strong leadership to try to achieve the best outcome for the patient and her team. Jenny was a pleasure to work with."